Thomas Pincez: Revised Guidelines Improve Care for Pediatric Immune Thrombocytopenia
Thomas Pincez, Adjunct Professor at McGill University, Assistant Professor at University of Montreal, Clinician-Scientist at Azrieli Research Centre of CHU Sainte-Justine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“How a simple change in practice can have a significant impact on the care of children with newly diagnosed immune thrombocytopenia.
Thanks for this great collaboration between the emergency, pediatrics and hematology teams!
Including those one Linkedin, Brigitte Parisien and Yves Pastore.”
Title: Improvement of newly diagnosed immune thrombocytopenia management in children by implementing revised practice guidelines
Authors: Cléo Hautefeuille, Myriam Coté, Brigitte Parisien, Evelyne D. Trottier, Yves D Pastore, Thomas Pincez
Read the Full Article on Oxford Academic
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 2, 2026, 08:22Chokri Ben Lamine: Laboratory Findings and Management of Severe Type 3 von Willebrand Disease
-
Apr 2, 2026, 08:12Heghine Khachatryan: Dementia at the Intersection of Hematology and Hemostasis
-
Apr 2, 2026, 04:47Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences
-
Apr 2, 2026, 04:28Mohammed Almohammadi: Etiologic Spectrum and Diagnostic Challenges of Hypocellular Marrow Findings
-
Apr 2, 2026, 04:18Emmanuele Kouvousis: Physical Inactivity as a Leading Global Health Risk
-
Apr 2, 2026, 04:03Robert Lufkin: The Misleading Concept of Metabolically Healthy Obesity in Childhood
-
Apr 1, 2026, 23:00Wolfgang Miesbach: What Goes Wrong When Approved Gene Therapies Get Withdrawn?
-
Apr 1, 2026, 22:00Aurelio Maggio: Congratulations to Mariasanta Napolitano on Her 1st Year Leading the Haematology and Rare Disease Uni tat ”V. Cervello” Hospital
-
Apr 1, 2026, 21:21Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality